Acuamark Diagnostics, Inc

AcuamarkDx is developing unique tests to accurately detect early cancer from blood when it can be cured - first for CRC early detection, then for all-cancers.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded December 2013
  • Employees 4
  • Incorporation Type C-corp
  • Website acuamarkdx.com

Company Summary

AcuamarkDx is developing first-in-kind, highly-accurate, affordable and scalable blood tests to detect early-stage cancer when it can be cured.

AcuamarkDx's first product is a blood test for early-stage detection of colorectal cancer (CRC). Its second product is an all-cancer early detection blood test.

AcuamarkDx has demonstrated detection proof-of-concept on human plasma samples from confirmed CRC patients.

(Offices: New York)

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free